Seth Lowry
Directeur/Membre du Conseil chez Cardea Bio, Inc.
Profil
Seth Lowry is currently a Director at Cardea Bio, Inc. and a Director of Research at Wingspan Capital LLC.
He received his undergraduate degree from the University of Colorado Boulder in 2007.
Postes actifs de Seth Lowry
| Sociétés | Poste | Début |
|---|---|---|
Cardea Bio, Inc.
 Cardea Bio, Inc. BiotechnologyHealth Technology Cardea Bio, Inc. develops bioelectronics for use in research and diagnostics. Its products include AGILE 100 and pipeline. The company was founded by Ross Bundy, Kiana Aran, and Brett Goldsmith in 2013 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - |
Wingspan Capital LLC
 Wingspan Capital LLC Investment ManagersFinance Wingspan Capital LLC (Wingspan Capital) is a private equity firm founded in 2019 by Andrew Eberhart. The firm is headquartered in New York. | Directeur/Membre du Conseil | 01/12/2022 |
Formation de Seth Lowry
| University of Colorado Boulder | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Cardea Bio, Inc.
Cardea Bio, Inc. BiotechnologyHealth Technology Cardea Bio, Inc. develops bioelectronics for use in research and diagnostics. Its products include AGILE 100 and pipeline. The company was founded by Ross Bundy, Kiana Aran, and Brett Goldsmith in 2013 and is headquartered in San Diego, CA. | Health Technology |
Wingspan Capital LLC
Wingspan Capital LLC Investment ManagersFinance Wingspan Capital LLC (Wingspan Capital) is a private equity firm founded in 2019 by Andrew Eberhart. The firm is headquartered in New York. | Finance |
